These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2504591)

  • 21. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of renal failure on ciprofloxacin pharmacokinetics in rats.
    Nouaille-Degorce B; Veau C; Dautrey S; Tod M; Laouari D; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1998 Feb; 42(2):289-92. PubMed ID: 9527774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.
    Sahai J; Healy DP; Stotka J; Polk RE
    Br J Clin Pharmacol; 1993 Mar; 35(3):302-4. PubMed ID: 8471407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cephradine administered intravenously and orally to young and elderly subjects.
    Schwinghammer TL; Norden CW; Gill E
    J Clin Pharmacol; 1990 Oct; 30(10):893-9. PubMed ID: 2229449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
    Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
    Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.
    Wingender W; Graefe KH; Gau W; Förster D; Beermann D; Schacht P
    Eur J Clin Microbiol; 1984 Aug; 3(4):355-9. PubMed ID: 6489326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
    Gath J; Charles B; Sampson J; Smithurst B
    J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
    Christensson BA; Nilsson-Ehle I; Ljungberg B; Lindblad A; Malmborg AS; Hjelte L; Strandvik B
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2512-7. PubMed ID: 1489195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects.
    Welker HA
    J Pharm Pharmacol; 1998 Sep; 50(9):983-7. PubMed ID: 9811158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.
    Fleishaker JC
    Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of renal function on the bioavailability of ciprofloxacin.
    Plaisance KI; Drusano GL; Forrest A; Weir MR; Standiford HC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1031-4. PubMed ID: 2393263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
    Catchpole C; Andrews JM; Woodcock J; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics in the elderly. Studies on ciprofloxacin.
    Lebel M; Bergeron MG
    Am J Med; 1987 Apr; 82(4A):108-14. PubMed ID: 3555025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absolute oral bioavailability of ciprofloxacin.
    Drusano GL; Standiford HC; Plaisance K; Forrest A; Leslie J; Caldwell J
    Antimicrob Agents Chemother; 1986 Sep; 30(3):444-6. PubMed ID: 3777908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of temazepam in the young and elderly.
    Kamali F; Herd B; Edwards C; Nicholson E; Wynne H
    J Clin Pharm Ther; 1994 Apr; 19(2):105-9. PubMed ID: 8071389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.